BioCentury
ARTICLE | Company News

Novo Nordisk sales and marketing update

April 27, 2015 7:00 AM UTC

Novo Nordisk launched Saxenda liraglutide in the U.S. for weight management as an adjunct to diet and exercise in adults with a BMI of at least 30 or a BMI of at least 27 and at least one co-morbidit...